Use of heat shock protein inhibitors for the treatment of neurodevelopmental disorders 【IF: 0】Patent: US20230218577A1 2023 Jul CUDC-305 purchased from AbMole
Patent. WO2023099929A1 【IF: 0】Patent. WO2023099929A1 2023 Jun 08 Eprenetapopt purchased from AbMole
Patent. CN116554248A 【IF: 0】Patent. CN116554248A 2023 Aug 08 Acetaminophen purchased from AbMole
Patent. CN117074141A 【IF: 0】Patent. CN117074141A 2023 Nov 17 Y-27632 dihydrochloride purchased from AbMole
Patent. CN116059199B 【IF: 0】Patent. CN116059199B 2023 Jul 18 2-NBDG purchased from AbMole
Patent. CN116731968A 【IF: 0】Patent. CN116731968A 2023 Sep 12 Y-27632 dihydrochloride purchased from AbMole
Progesterone is an Inducement of Heritable Pulmonary Arterial Hypertension with BMPR2 Mutation 【IF: 0】bioRxiv. 2023 Jun Mifepristone purchased from AbMole
Patent. CN116987669A 【IF: 0】Patent. CN116987669A 2023 Nov 03 Y-27632 dihydrochloride purchased from AbMole
Patent. EP4260907A1 【IF: 0】Patent. EP4260907A1 2023-10-18 Y-27632 dihydrochloride purchased from AbMole
Patent. CN112500288A 【IF: 0】Patent. CN112500288A 2023-02-03 Cell Counting Kit-8 purchased from AbMole
Patent. CN114606192B 【IF: 0】Patent. CN114606192B 2023 Aug 08 Y-27632 dihydrochloride purchased from AbMole
Patent. US2023043374A1 【IF: 0】Patent. US2023043374A1 2023 Feb 09 Tofacitinib purchased from AbMole
Products are for research use only. Not for human use. We do not sell to patients.© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
